Kyoko Oura

Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C

Koji Fujita, Kyoko Oura, Hirohito Yoneyama et al. · Hepatology Research · 2019 · 66 citations · Full text

Medicine, Internal Medicine, Pathology +17

Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct‑acting antiviral treatment: All Kagawa Liver Disease Group Study

Joji Tani, Asahiro Morishita, Teppei Sakamoto et al. · Oncology Letters · 2020 · 55 citations · Full text

Medicine, Infectious Diseases, Oncology +16

APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024

George Lau, Shuntaro Obi, Jian Zhou et al. · Hepatology International · 2024 · 51 citations · Full text

Medicine, Immunology, Oncology +17

Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest

Eri Samukawa, Shintaro Fujihara, Kyoko Oura et al. · International Journal of Oncology · 2017 · 50 citations · Full text

Medicine, Oncology, Pharmacology +13

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest

Kyoko Oura, Tomoko Tadokoro, Shintaro Fujihara et al. · Oncology Reports · 2017 · 49 citations · Full text

Medicine, Oncology, Pharmacology +13